0001209191-20-027781.txt : 20200507
0001209191-20-027781.hdr.sgml : 20200507
20200507183739
ACCESSION NUMBER: 0001209191-20-027781
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200505
FILED AS OF DATE: 20200507
DATE AS OF CHANGE: 20200507
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Janssen Robert
CENTRAL INDEX KEY: 0001580849
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34207
FILM NUMBER: 20858111
MAIL ADDRESS:
STREET 1: C/O DYNAVAX TECHNOLOGIES
STREET 2: 2929 SEVENTH STREET, SUITE 100
CITY: BERKELEY
STATE: CA
ZIP: 94710
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: DYNAVAX TECHNOLOGIES CORP
CENTRAL INDEX KEY: 0001029142
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 330728374
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2100 POWELL STREET
STREET 2: SUITE 900
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
BUSINESS PHONE: 5108485100
MAIL ADDRESS:
STREET 1: 2100 POWELL STREET
STREET 2: SUITE 900
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-05-05
0
0001029142
DYNAVAX TECHNOLOGIES CORP
DVAX
0001580849
Janssen Robert
C/O DYNAVAX TECHNOLOGIES
2100 POWELL STREET, SUITE 900
EMERYVILLE
CA
94608
0
1
0
0
Senior Vice President
Common Stock
2020-05-05
4
S
0
9000
4.43
D
220266
D
Common Stock
2020-05-06
4
S
0
28000
4.52
D
192266
D
The sales reported on this Form 4 were effected pursuant to a 10b5-1 trading plan.
This transaction was executed in multiple trades at prices ranging from $4.40 to $4.45; the price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full
information regarding the number of shares and prices at which the transactions were effected upon request to the SEC staff, Dynavax, or a security holder of Dynavax.
This transaction was executed in multiple trades at prices ranging from $4.40 to $4.60; the price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions were effected upon request to the SEC staff, Dynavax, or a security holder of Dynavax.
/s/ Robert Janssen
2020-05-07